APCS 抗体

Sponarova, Nuvolone, Whicher, Frei, Kana, Schwarz, Westermark, Aguzzi: "Efficient amyloid A clearance in the absence of immunoglobulins and complement factors." in: The American journal of pathology, Vol. 182, Issue 4, pp. 1297-307, (2013) (PubMed).

Ramos-Sevillano, Rodríguez-Sosa, Cafini, Giménez, Navarro, Sevillano, Alou, García, Aguilar, Yuste: "Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains." in: PLoS ONE, Vol. 7, Issue 9, pp. e44135, (2012) (PubMed).

Maher, Dargusch, Ehren, Okada, Sharma, Schubert: "Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes." in: PLoS ONE, Vol. 6, Issue 6, pp. e21226, (2011) (PubMed).

Veerhuis, Boshuizen, Morbin, Mazzoleni, Hoozemans, Langedijk, Tagliavini, Langeveld, Eikelenboom: "Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q." in: Neurobiology of disease, Vol. 19, Issue 1-2, pp. 273-82, (2005) (PubMed).

Maeda: "Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition." in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, Vol. 10 Suppl 1, pp. 17-20, (2003) (PubMed).

Hawkins: "Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis." in: Current opinion in nephrology and hypertension, Vol. 11, Issue 6, pp. 649-55, (2002) (PubMed).

de Haas: "New insights into the role of serum amyloid P component, a novel lipopolysaccharide-binding protein." in: FEMS immunology and medical microbiology, Vol. 26, Issue 3-4, pp. 197-202, (2000) (PubMed).